BridgeMD
New treatment option for Stroke
Official title Mixed Reality and Virtual Reality Technology With Mirror Therapy for Stroke Rehabilitation
ClinicalTrials.gov ID: NCT05903235
What this study is testing
- What it's testing
- The specific study aims will be: 1. To design and develop the hardware and software of the VR+MT and MR+MT systems.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 80
You may be able to join if
- Phase Ⅰ: Design and Development of the VR+MT and MR+MT Systems \& Feasibility Study
- diagnosed with unilateral stroke
- age of 20 to 80 years
- a baseline Fugl-Meyer Assessment of the Upper Extremity score of 20 to 60
- able to follow the study instructions and provide the feedback of user experiences verbally
You likely can't join if
- diagnosed with global or receptive aphasia
- the presence of severe neglect
- the existence of major medical problems or comorbidities that could interfere with upper-limb usage and pain, or disrupt visual or auditory...
- diagnosed with unilateral stroke
- more than 6 months after stroke onset
- age of 20 to 80 years
See the full eligibility criteria
- Phase Ⅰ: Design and Development of the VR+MT and MR+MT Systems \& Feasibility Study
- diagnosed with unilateral stroke
- age of 20 to 80 years
- a baseline Fugl-Meyer Assessment of the Upper Extremity score of 20 to 60
- able to follow the study instructions and provide the feedback of user experiences verbally
- diagnosed with global or receptive aphasia
- the presence of severe neglect
- the existence of major medical problems or comorbidities that could interfere with upper-limb usage and pain, or disrupt visual or auditory perception Phase Ⅱ: Validation and Comparison of Clinical Treatment how well it...
- diagnosed with unilateral stroke
- more than 6 months after stroke onset
- age of 20 to 80 years
- a baseline Fugl-Meyer Assessment of the Upper Extremity score of 20 to 60
- able to follow the study instructions
- capable of participating in the assessment process and treatment program Exclusion Criteria:
- diagnosed with global or receptive aphasia
- the presence of severe neglect
- the existence of major medical problems or comorbidities that could interfere with upper-limb usage and pain, or disrupt visual or auditory perception
The study team makes the final eligibility decision.
Where it's taking place
- Taoyuan City, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Taoyuan City, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.